Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | RORA | P35398 | 1/20 | 0.51 |
| ▸ | RORC | P51449 | 1/20 | 0.51 |
| ▸ | RORB | Q92753 | 1/20 | 0.51 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 2/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12083594 | 0.90 | RORA (0.46) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL1102532 | 0.89 | GPR3 (0.55) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL12570842 | 0.89 | GPR3 (0.59) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL8091816 | 0.86 | NPC1 (0.56) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL15783209 | 0.86 | GPR3 (0.52) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL25765615 | 0.85 | MEN1 (0.58) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL21374983 | 0.84 | GPR3 (0.53) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL24667564 | 0.84 | RORC (0.47) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL27276344 | 0.83 | RORA (0.44) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL12083593 | 0.83 | GPR3 (0.52) | GPR3KDM4EMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240215444-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| US-9593069-B2 | Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2017-03-14 | — | — | US | disclosed |
| US-20160301015-A1 | LIGHT-EMITTING COMPOUNDS FOR LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2016-10-13 | — | — | US | disclosed |
| US-20160039740-A1 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis | CAMBRIA PHARMACEUTICALS DISTRIBUTING TRUST | 2016-02-11 | — | — | US | disclosed |
| US-9162968-B2 | Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2015-10-20 | — | — | US | disclosed |
| US-9112159-B2 | Bipolar hosts for light emitting devices | NITTO DENKO CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20140371313-A1 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis | CAMBRIA PHARMACEUTICALS DISTRIBUTING TRUST | 2014-12-18 | — | — | US | disclosed |
| US-20140163237-A1 | BIPOLAR HOSTS FOR LIGHT EMITTING DEVICES | Nitto Denko Corportion (JP) | 2014-06-12 | — | — | US | disclosed |
| US-8722939-B2 | Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2014-05-13 | — | — | US | disclosed |
| US-8716489-B2 | Oxadiazole derivative, light-emitting element material, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-06 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-26 | — | — | US | disclosed |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-26 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090260686-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
| US-20090260686-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090260686-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, FZD7 | GPR3 2280/4885KDM4E 3940/4885MAPT 3625/4885 |
| US-20240215444-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME | NFE2L2, SLC1A2, CRY1 | GPR3 3733/4885KDM4E 2828/4885MAPT 2246/4885 |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, ORMDL3, CHRM2 | GPR3 2495/4885KDM4E 3872/4885MAPT 3474/4885 |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OXER1, L1CAM, RPL41 | GPR3 744/4885KDM4E 4525/4885MAPT 3423/4885 |
| US-20140371313-A1 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis | SMN1; SMN2, HTT, CPT1B | GPR3 1984/4885KDM4E 1392/4885MAPT 259/4885 |
| US-20160039740-A1 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis | SMN1; SMN2, HTT, CPT1B | GPR3 1984/4885KDM4E 1392/4885MAPT 259/4885 |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | GPR3 3079/4885KDM4E 3298/4885MAPT 1948/4885 |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | GPR3 1503/4885KDM4E 3367/4885MAPT 3162/4885 |
| US-20160301015-A1 | LIGHT-EMITTING COMPOUNDS FOR LIGHT-EMITTING DEVICES | CRY1, ALDH1A2, CRY2 | GPR3 2778/4885KDM4E 3735/4885MAPT 970/4885 |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | OCIAD1, OCIAD2, ORMDL3 | GPR3 3460/4885KDM4E 3509/4885MAPT 1219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.